Realfiction (REALFI) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
23 Nov, 2025Technology and Product Development
Focus has shifted from legacy 3D display products to Directional Pixel Technology (DPT), enabling glasses-free, multi-user 3D with no resolution loss and advanced multi-view capabilities.
DPT uses a spatial light modulator (SLM) to direct light electronically, allowing for dynamic, high-resolution, multi-user 3D and 2D multiview experiences.
The SLM is being iterated to address image imperfections and integrate ferroelectric crystals (FLC) for higher speed and more features, with GoWorld leading development at minimal cost to the company.
DPT is compatible with major display technologies, including LCD, OLED, LED, and MicroLED, and can be modular for large-scale displays.
AI is seen as a future driver for content and software, with current focus on hardware integration in display panels.
Business Model and Partnerships
The business model is based on technology licensing to display manufacturers, with revenue expected from upfront NRE fees and per-unit licensing as products reach mass production.
Key partnerships include GoWorld (panel manufacturing), PlayNitride (MicroLED collaboration), and AmTRAN (legacy product manufacturing and future integration).
GoWorld provides significant development resources for SLM iterations, while PlayNitride collaboration led to the first glasses-free 3D MicroLED display, attracting industry attention.
Negotiations with large panel makers are ongoing, with cultural and industry skepticism being gradually overcome through demonstrations and partnerships.
IP strategy emphasizes maintaining broad licensing rights, balancing customer exclusivity demands with the goal of wide DPT adoption.
Commercialization and Financial Outlook
First DPT revenue came from a confidential entertainment industry project requiring multi-view 2D, with successful POC delivery.
NRE and upfront payments from multiple customer projects are targeted for 2025–2026, with volume-based licensing revenue expected from late 2026 or early 2027.
Current SLM is sufficient for some deals, while new iterations will expand capabilities and address specific customer requirements.
The ongoing rights issue is 60% guaranteed, providing a chance to reach break-even even at this level, with further subscription increasing growth potential.
Confidence remains high in converting current project discussions into concrete agreements, with ongoing efforts to onboard new clients.
Latest events from Realfiction
- Sharp revenue drop in Q3 as DPT sales paused; capital raised to support DPT commercialization.REALFI
Q3 202527 Nov 2025 - DPT commercialization advances with improved margins and new funding, despite lower revenue.REALFI
Q2 202528 Jul 2025 - Q3-2024 saw record DPT-driven revenue growth and strong gross margins, with liquidity secured.REALFI
Q3 202413 Jun 2025 - Q2-2024 saw strong revenue growth and DPT licensing talks nearing a breakthrough.REALFI
Q2 202413 Jun 2025 - DPT commercialization accelerates with new funding and industry milestones despite lower revenue.REALFI
Q1 20256 Jun 2025 - Revenue surged and DPT commercialization advanced with a pivotal license agreement.REALFI
Q4 20245 Jun 2025